Healthcare -
Biotechnology - NASDAQ - US
$ 3.62
-3.21 %
$ 124 M
Market Cap
-1.37
P/E
TARA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TARA - Protara Therapeutics, Inc.
53.1 M
LAST VALUE
59.40%
2 YEAR CAGR
23.58%
5 YEAR CAGR
34.57%
10 YEAR CAGR